ScholarLens Back to search
1988•Journal of Neurology Neurosurgery & PsychiatryOpen access

Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Paul Lyons, Peter Newman, M Saunders

Open full text 72 citations

Abstract

A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.

Open-access reader

About this research paper

What this paper is about

A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.

Why it matters

OpenAlex reports 72 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.

Key concepts: Methylprednisolone, Multiple sclerosis, Adverse effect, Medicine, Retrospective cohort study, Therapeutic effect, Internal medicine, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. — Research Paper | ScholarLens